Evidence map›Paper›PMID 30388402›Full record

ArticleAmerican journal of human genetics2018

NFIB Haploinsufficiency Is Associated with Intellectual Disability and Macrocephaly.

Ina Schanze, Jens Bunt, Jonathan W C Lim, Denny Schanze, Ryan J Dean, Marielle Alders, Patricia Blanchet, Tania Attié-Bitach, Siren Berland, Steven Boogert and 39 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. scCompass: An Integrated Multi-Species scRNA-seq Database for AI-Ready.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

49 authors at 20 institutions in 9 countries.

Ina SchanzeInstitute of Human Genetics, University Hospital Magdeburg, Otto-von-Guericke University, Magdeburg 39120, Germany.
Jens BuntQueensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia. Electronic address: j.bunt@uq.edu.au.
Jonathan W C LimQueensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia.
Denny SchanzeInstitute of Human Genetics, University Hospital Magdeburg, Otto-von-Guericke University, Magdeburg 39120, Germany.
Ryan J DeanQueensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia.
Marielle AldersDepartment of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam 1105 AZ, the Netherlands.
Patricia BlanchetINSERM U1183, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Génétique clinique, CHU Montpellier, Université Montpellier, Centre de référence anomalies du développement SORO, Montpellier 34295, France.
Tania Attié-BitachINSERM U1163, Laboratory of Embryology and Genetics of Congenital Malformations, Paris Descartes University, Sorbonne Paris Cité and Imagine Institute, Paris 75015, France.
Siren BerlandDepartment of Medical Genetics, Haukeland University Hospital, Bergen 5021, Norway.
Steven BoogertInstitute of Human Genetics, University Hospital Magdeburg, Otto-von-Guericke University, Magdeburg 39120, Germany.
Sangamitra BoppudiInstitute of Human Genetics, University Hospital Magdeburg, Otto-von-Guericke University, Magdeburg 39120, Germany.
Caitlin J BridgesInstitute of Human Genetics, University Hospital Magdeburg, Otto-von-Guericke University, Magdeburg 39120, Germany.
Megan T ChoGeneDx, Gaithersburg, MD 20877, USA.
William B DobynsDepartment of Pediatrics (Genetics), University of Washington and Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA 98101, USA.
Dian DonnaiManchester Centre for Genomic Medicine, Manchester Academic Health Science Centre, Central Manchester University Hospitals NHS Foundation Trust; Division of Evolution and Genomic Sciences School of Biological Sciences, and University of Manchester, Manchester M13 9WL, UK.
Jessica DouglasBoston Children's Hospital - The Feingold Center, Waltham, MA 02115, USA.
Dawn L EarlDivision of Genetic Medicine, Seattle Children's Hospital, Seattle, WA 98105, USA.
Timothy J EdwardsQueensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia; The Faculty of Medicine Brisbane, The University of Queensland, Brisbane, QLD 4072, Australia.
Laurence FaivreUMR1231, Génétique des Anomalies du Développement, Université de Bourgogne, Dijon 21079, France; Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Interrégion Est et FHU TRANSLAD, Centre Hospitalier Universitaire Dijon, Dijon 21079, France.
Brieana FregeauDepartment of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA.
David GenevieveINSERM U1183, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Génétique clinique, CHU Montpellier, Université Montpellier, Centre de référence anomalies du développement SORO, Montpellier 34295, France.
Marion GérardService de Génétique, CHU de Caen - Hôpital Clémenceau, Caen Cedex 14000, France.
Vincent GatinoisINSERM U1183, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Génétique clinique, CHU Montpellier, Université Montpellier, Centre de référence anomalies du développement SORO, Montpellier 34295, France.
Muriel Holder-EspinasseService de Génétique Clinique, Hôpital Jeanne de Flandre, CHU Lille, Lille 59000, France; Department of Clinical Genetics, Guy's Hospital, London SE1 9RT, UK.
Samuel F HuthQueensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia.
Kosuke IzumiDepartment of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA; Division of Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Bronwyn KerrManchester Centre for Genomic Medicine, Manchester Academic Health Science Centre, Central Manchester University Hospitals NHS Foundation Trust; Division of Evolution and Genomic Sciences School of Biological Sciences, and University of Manchester, Manchester M13 9WL, UK.
Elodie LacazeDepartment of genetics, Le Havre Hospital, 76600 Le Havre, France.
Phillis LakemanDepartment of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam 1105 AZ, the Netherlands.
Sonal MahidaDepartment of Neurogenetics, Kennedy Krieger Institute, Baltimore, MD 21205, USA.
Ghayda M MirzaaDepartment of Pediatrics (Genetics), University of Washington and Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA 98101, USA.
Sian M MorganAll Wales Genetics Laboratory, Institute of Medical Genetics, University Hospital of Wales, Cardiff CF14 4XW, UK.
Catherine NowakBoston Children's Hospital - The Feingold Center, Waltham, MA 02115, USA.
Hilde PeetersCenter for Human Genetics, University Hospital Leuven, KU Leuven, Leuven 3000, Belgium.
Florence PetitService de Génétique Clinique, Hôpital Jeanne de Flandre, CHU Lille, Lille 59000, France.
Daniela T PilzWest of Scotland Genetics Service, Queen Elizabeth University Hospital, Glasgow G51 4TF, UK.
Jacques PuechbertyINSERM U1183, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Génétique clinique, CHU Montpellier, Université Montpellier, Centre de référence anomalies du développement SORO, Montpellier 34295, France.
Eyal ReinsteinMedical Genetics Institute, Meir Medical Center, Kfar-Saba 4428164, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Jean-Baptiste RivièreUMR1231, Génétique des Anomalies du Développement, Université de Bourgogne, Dijon 21079, France; Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Interrégion Est et FHU TRANSLAD, Centre Hospitalier Universitaire Dijon, Dijon 21079, France; Child Health and Human Development Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
Avni B SantaniDivision of Genomic Diagnostics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Anouck SchneiderINSERM U1183, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Génétique clinique, CHU Montpellier, Université Montpellier, Centre de référence anomalies du développement SORO, Montpellier 34295, France.
Elliott H SherrDepartment of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA.
Constance Smith-HicksDepartment of Neurogenetics, Kennedy Krieger Institute, Baltimore, MD 21205, USA.
Ilse WielandInstitute of Human Genetics, University Hospital Magdeburg, Otto-von-Guericke University, Magdeburg 39120, Germany.
Elaine ZackaiDepartment of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
Xiaonan ZhaoDivision of Genomic Diagnostics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Richard M GronostajskiDepartment of Biochemistry, Program in Genetics, Genomics and Bioinformatics, Center of Excellence in Bioinformatics and Life Sciences, State University of New York at Buffalo, Buffalo, NY 14203, USA.
Martin ZenkerInstitute of Human Genetics, University Hospital Magdeburg, Otto-von-Guericke University, Magdeburg 39120, Germany. Electronic address: martin.zenker@med.ovgu.de.
Linda J RichardsQueensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia; School of Biomedical Sciences, The Faculty of Medicine Brisbane, The University of Queensland, Brisbane, QLD 4072, Australia.
University Hospital Magdeburg · DEAllen Institute for Brain Science · USInserm · FRChildren's Hospital of Philadelphia · USSeattle Children's Hospital · USAmsterdam UMC Location University of Amsterdam · NLBoston Children's Hospital · USCentre Hospitalier Universitaire de Lille · FRCHU Dijon Bourgogne · FRKennedy Krieger Institute · USManchester Academic Health Science Centre · GBUniversity of California, San Francisco · USCentre Hospitalier Universitaire de Caen Normandie · FRDélégation Paris 5 · FRHaukeland University Hospital · NOKU Leuven · BEMeir Medical Center · ILQueen Elizabeth University Hospital · GBThe University of Queensland · AUUniversité Le Havre Normandie · FR

Funding

De novo copy number variation and gene discovery in human brain malformationsR01NS058721 · NINDS · UNIVERSITY OF CHICAGO · PI ARGILLI, EMANUELA · 2008 to 2025
$10.9M
Megalencephaly and segmental brain overgrowth in humansR01NS092772 · NINDS · SEATTLE CHILDREN'S HOSPITAL · PI MILLEN, KATHLEEN JOYCE · 2015 to 2019
$3.3M
Genes and pathways underlying brain overgrowth and focal cortical malformationsK08NS092898 · NINDS · SEATTLE CHILDREN'S HOSPITAL · PI MIRZAA, GHAYDA · 2015 to 2019
$930k
NINDS NIH HHS K08 NS092898NINDS NIH HHS R01 NS058721NINDS NIH HHS R01 NS092772
6 · The paper itself

Abstract

The nuclear factor I (NFI) family of transcription factors play an important role in normal development of multiple organs. Three NFI family members are highly expressed in the brain, and deletions or sequence variants in two of these, NFIA and NFIX, have been associated with intellectual disability (ID) and brain malformations. NFIB, however, has not previously been implicated in human disease. Here, we present a cohort of 18 individuals with mild ID and behavioral issues who are haploinsufficient for NFIB. Ten individuals harbored overlapping microdeletions of the chromosomal 9p23-p22.2 region, ranging in size from 225 kb to 4.3 Mb. Five additional subjects had point sequence variations creating a premature termination codon, and three subjects harbored single-nucleotide variations resulting in an inactive protein as determined using an in vitro reporter assay. All individuals presented with additional variable neurodevelopmental phenotypes, including muscular hypotonia, motor and speech delay, attention deficit disorder, autism spectrum disorder, and behavioral abnormalities. While structural brain anomalies, including dysgenesis of corpus callosum, were variable, individuals most frequently presented with macrocephaly. To determine whether macrocephaly could be a functional consequence of NFIB disruption, we analyzed a cortex-specific Nfib conditional knockout mouse model, which is postnatally viable. Utilizing magnetic resonance imaging and histology, we demonstrate that Nfib conditional knockout mice have enlargement of the cerebral cortex but preservation of overall brain structure and interhemispheric connectivity. Based on our findings, we propose that haploinsufficiency of NFIB causes ID with macrocephaly.

Indexed as

AdolescentAdultAnimalsCerebral CortexChildChild, PreschoolCodon, NonsenseCohort StudiesCorpus CallosumFemaleHaploinsufficiencyHumansIntellectual DisabilityMaleMegalencephalyMiceCodon, NonsenseNFIB protein, humanNFI Transcription Factorsagenesis of the corpus callosumchromosome 9p22.3chromosome 9p23developmental delayhaploinsufficiencyintellectual disabilitymacrocephalymegalencephalyNFIBnuclear factor I

Identifiers

PMID30388402
PMCPMC6218805
OpenAlexW2898850951

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.